COURTNEY OAKES: Open Payments
NPI 1033830609 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,071 in 112 payments from 21 companies in 2025. Trend: 2023 $1,478 · 2024 $1,803 · 2025 $2,071
Food & beverage: $2,071
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $527 |
| PFIZER INC. | 16 | $251 |
| Novo Nordisk Inc | 8 | $236 |
| AstraZeneca Pharmaceuticals LP | 7 | $191 |
| Lilly USA, LLC | 11 | $174 |
| Amgen Inc. | 12 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $77 |
| Corcept Therapeutics | 4 | $72 |
| Lundbeck LLC | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
Products named: VRAYLAR, Ozempic, AIRSUPRA, MOUNJARO, ELIQUIS, JARDIANCE, EVENITY, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
